AMICUS THERAPEUTICS, INC. — Director's Dealing 2023

Aug 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2023-08-21

Reporting Person: Harford Simon N.R. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-21	Common Stock	A	106973	$0.00	Acquired	106973	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-08-21	Stock Options (right to buy)	$12.62	A	189043	Acquired	2033-08-21	Common Stock (189043)	Direct

Footnotes

F1: Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on August 21, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.

F2: These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.